Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Meningococcal Meningitis, Serogroup A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01897402
What this trial is testing

Immunogenicity and Safety of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 525
Testing effectiveness (Phase 2)Study completedNCT01461980
What this trial is testing

A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age

Who this might be right for
VaccinesMeningococcal Vaccines
Pfizer 2,648
Large-scale testing (Phase 3)Study completedNCT00616421
What this trial is testing

Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children

Who this might be right for
Meningococcal Infections
Novartis Vaccines 2,907
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT00355121
What this trial is testing

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Who this might be right for
Meningococcal MeningitisTetanusDiphtheria+2 more
Sanofi 882
Testing effectiveness (Phase 2)Study completedNCT00771849
What this trial is testing

Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 103
Large-scale testing (Phase 3)Study completedNCT01973218
What this trial is testing

Safety and Immunogenicity Study of Two Doses of Novartis Meningococcal Serogroup B Recombinant Vaccine in Adolescents Aged 11-17 Years.

Who this might be right for
Meningococcal Disease
Novartis Vaccines 264
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Testing effectiveness (Phase 2)Study completedNCT00297817
What this trial is testing

Study of the Safety and Immune Response of Two Serogroup B Meningococcal Vaccines Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
Novartis Vaccines 203
Post-approval studies (Phase 4)Study completedNCT00119080
What this trial is testing

Effect of Meningococcal Conjugate Vaccine on Meningococcal Carriage

Who this might be right for
Meningitis
Centers for Disease Control and Prevention 4,000
Large-scale testing (Phase 3)Study completedNCT05093829
What this trial is testing

Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine

Who this might be right for
Meningitis
Emory University 1,325